Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
48
result was found. Results that relate to
Drugs
Analysis on application of new anti-tumor drugs for respiratory system in 121 hospitals in China from 2019 to 2022
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(1):27-34.
7554 times
1108 times
XING Yue
LIU Tong
ZHONG Lu
JIN Yao
TENG Xue
New anti-tumor
drugs
for respiratory system
Targeted
drugs
Immunotherapy
drugs
DDDs
DDC
Ranking ratio
Drug utilization
Details
Consistency investigation on rheological properties of adapalene gel original drug and generic drugs
Published on
Frontiers in Pharmaceutical Sciences
2025,29(1):33-39.
12052 times
1659 times
WANG Jingwei
CHEN Xiaoyong
YUAN Yi
LIU Chenxi
HU Min
Adapalene gel
Rheology
Pseudoplastic fluids
Generic
drugs
Original drug
Consistency evaluation
Viscosity
Details
Visualization analysis on global research progress and trends of anti-infective drug-induced nephrotoxicity from 2014 to 2024
Published on
Frontiers in Pharmaceutical Sciences
2025,29(1):97-105.
8975 times
1015 times
WANG Pengkai
YUAN Fang
LIU Candi
YANG Yuan
LI Xin
Anti-infective
drugs
Nephrotoxicity
Bibliometric
Acute kidney injury
Cluster analysis
Oxidative stress
Apoptosis
Ferroptosis
Vancomycin
Polymyxins
Aminoglycosides
Details
A multicenter cross-sectional survey on the medical order review status of Pharmacy Intravenous Admixture Services in Hebei Province
Published on
Frontiers in Pharmaceutical Sciences
2025,29(2):327-333.
7460 times
1018 times
PANG Guoxun
YUE Yuanyuan
WANG Yang
ZHAO Yanan
WANG Zhiheng
LIU Shan
Pharmacy Intravenous Admixture Services
Questionnaire
Medical order review
Cross-sectional research
Rational use of
drugs
Details
Practice of information management of special accounts for drugs under special management categories
Published on
Frontiers in Pharmaceutical Sciences
2025,29(3):485-490.
5033 times
986 times
JIANG Xin
LIANG Gaoheng
LIN Zhenzhen
GUO Junfen
ZHONG Qinlong
JIANG Cheng
Toxic
drugs
Vaccines
Anesthetic
drugs
Class Ⅰ psychotropic
drugs
Class Ⅱ psychotropic
drugs
Controlled substances
Specialized account books
Informatization
Details
Perioperative infection and antibacterial strategies in liver transplantation
Published on
Frontiers in Pharmaceutical Sciences
2025,29(3):525-530.
5461 times
1009 times
YU Miao
DU Hang
WANG Wenhua
HUANG Yuru
Liver transplantation
Perioperative period
Infection
Antibacterial
drugs
Immunosuppressants
Details
Research progress on the analysis methods for phthalates plasticizers in pharmaceutical packaging materials and drugs
Published on
Frontiers in Pharmaceutical Sciences
2025,29(3):531-540.
5013 times
952 times
JIA Feifei
HAN Xiaoxu
ZHAO Xia
Phthalates
Plasticizer
Drugs
Pharmaceutical packaging materials
Compatibility
Safety
Pretreatment
Analytical methods
Details
Application effect of failure mode and effect analysis in the drug validity management of inpatient pharmacy
Published on
Frontiers in Pharmaceutical Sciences
2025,29(4):657-664.
6604 times
981 times
LI Shupei
YAO Zhaoying
CHEN Min
TAN Xiying
WANG Xiaomin
Failure mode and effect analysis
Inpatient pharmacy
Cardinal
drugs
Drug validity management
Details
The research progress of siRNA drugs in obesity
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(5):589-594.
13635 times
3386 times
JIANG Fengxuan
LU Qingmiao
LU Yibing
siRNA
drugs
Obesity
Weight loss
Delivery system
Details
Feasibility study on mercury-free green testing of hydrochloride salt drugs in the Chinese Pharmacopoeia
Published on
Frontiers in Pharmaceutical Sciences
2025,29(5):756-763.
6191 times
961 times
LIU Huiying
LI Shangying
HUANG Hai
XU Wankui
Hydrochloride
drugs
Method substitution
Mercury salt elimination
Green drug testing
Quality control
Details
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):690-701.
11384 times
1435 times
ZHANG Bin
LIU Minna
LI Xiaolin
LI Jinhu
LIU Tianlong
National centralized drug procurement
Real world study
Clinical evaluation
Generic
drugs
Innovator
drugs
Effectiveness
Safety
Details
The achievements and challenges of generic drugs under the centralized procurement policy
Published on
Frontiers in Pharmaceutical Sciences
2025,29(6):1073-1080.
8547 times
1018 times
LI Tiancheng
WANG Bofei
GUAN Yixuan
FENG Liping
GU Jia
LIU Peili
Centralized volume-based procurement of
drugs
Generic
drugs
Substitutability
Drug innovation
Details
Construction and practice of individualized medication guidance for cardiovascular chronic disease patients based on informatization
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1209-1214.
6076 times
714 times
YU Tianjian
ZHANG Jing
YU Xiongjie
CHEN Jinhua
Cardiovascular
drugs
Medication guidance
Informatization construction
Individuation
Details
Progress of SNAC for improving oral bioavailability of macromolecular drugs
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1254-1260.
9502 times
973 times
SHI Qiongzhi
XIE Xiangyang
LI Yinke
XU Hengjun
LIU Hui
SNAC
Permeation enhancer
Macromolecular
drugs
Oral bioavailability
Drug delivery
Details
Analysis of the impact of international research on dose rounding of anti-tumor drugs on the cost of anti-tumor drugs in China
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2065-2071.
1301 times
230 times
REN Lingzhi
YU Wenhao
WANG Ting
TANG Min
ZHOU Ziyuan
TANG Haochun
MENG Jun
Anti-tumor
drugs
Dose rounding
Drug cost
Cost saving
Healthcare expenses
Economic burden
Monoclonal antibody
Details
上一页
1
2
3
4
下一页